Symptomate
Symptomate is an AI-powered symptom checker and digital triage platform built by Infermedica, offering free consumer access via web and mobile apps and licensing its triage technology to healthcare providers and insurers across 14 languages.
- Company typePrivate
- Founded2012
- HeadquartersWroclaw, Poland
- Headcount11–50
- GTM typeB2B and B2C
- OfferingSoftware
What Symptomate does
Symptomate is a self-service symptom checker and digital triage platform developed and operated by Infermedica Sp. z o.o., a privately held Polish company headquartered in Wroclaw. The product consists of a web application and native iOS/Android apps that guide users through an AI-driven interview to surface probable conditions, explanations, and a recommended level of care across five tiers. Underlying the product is a proprietary AI-based inference engine layered onto a clinician-curated medical knowledge base that the company reports represents 155,000+ hours of physician work, with 27 million+ interviews conducted since launch in 2012 and 200,000+ interviews performed monthly. The platform is available in 14 languages and is registered as a Class IIb medical device under the EU MDR, developed under ISO 13485:2016, and compliant with GDPR and HIPAA.
The business operates a hybrid model. The consumer product is free and self-serve, generating no direct end-user revenue but functioning as a top-of-funnel asset and proof point for enterprise buyers. Monetization flows through Infermedica's B2B platform, which licenses Symptomate's technology to healthcare facilities, insurance providers, and other enterprises for integration into preliminary symptom assessment and triage workflows. Add-on modules (Infermedica Follow-Up and Health Report) extend the core product into longitudinal monitoring and intake, currently available only to US users. Distribution is product-led for consumers and direct enterprise sales for B2B, with no public disclosure of contract values, customer logos, or revenue.
The company's strategic posture is regulatory-first in Europe and distribution-led globally, with active expansion of the product surface (LLM-powered chatbot in beta, US-only add-ons) and geographic coverage spanning Europe, the Middle East, Latin America, and Asia. Consumer availability is restricted or unlicensed in Canada and Australia, and the company has not disclosed funding rounds, M&A, leadership hires, or financial results in the available data.
Symptomate firmographics
Firmographics- Name
- Symptomate
- Legal name
- Infermedica Spółka z ograniczoną odpowiedzialnością
- Website
- https://symptomate.com
- Company type
- Private
- Founded year
- 2012
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Symptomate is an AI-powered symptom checker and digital triage platform built by Infermedica, offering free consumer access via web and mobile apps and licensing its triage technology to healthcare providers and insurers across 14 languages.
- Ownership category
- akta.pro rank
Symptomate industry classification
Industry- Product category
- Digital Health Triage Software
- NAICS
- Medical and Diagnostic Laboratories (62151)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Symptom Checker & Self-Triage Platforms (HLALAJAB)
- akta.pro secondary industries
- Diagnostic & Triage Decision Support (HLACAGAA), 24/7 Nurse Line, Symptom Checker & Triage (Payer-Sponsored) (HLALACAB)
Keywords
Where Symptomate is headquartered
LocationHeadquarters
- HQ city
- Wroclaw
- HQ country
- Poland
- HQ region
- Europe
Offices1 record
Markets served
Symptomate business model
Business model- GTM type
- B2B and B2C
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales
Revenue model
- Consumer Self-Service (Free): Free symptom checking service for individual consumers through web and mobile applications
- B2B Enterprise Licensing: Licensing of Symptomate technology to healthcare facilities, insurance providers, and other companies for integration into their platforms to improve online preliminary symptom assessment and triage processes
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | Monthly | Free Consumer Access |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels4 records
Symptomate product offering
Product offeringCore offering
Symptomate is an AI-powered symptom checker and digital triage platform that allows users to input symptoms, risk factors, and health information through an adaptive interview to receive probability-based assessments of potential conditions along with five levels of care recommendations. The platform is delivered as a free consumer-facing web and mobile application (iOS/Android) and is also licensed to healthcare facilities, insurance providers, and other enterprises for integration into their preliminary symptom assessment and triage workflows.
Product overview
Symptomate is a digital symptom assessment and triage platform consisting of a core web application and mobile apps for iOS and Android. The platform is powered by an AI-based inference engine combined with a medical knowledge base to analyze user-reported symptoms and generate condition probability assessments. Additional optional services include Infermedica Follow-Up (for tracking health changes over time) and Health Report (for comprehensive health intake surveys), both available exclusively in the United States. The platform supports 14 languages and is certified as a Class IIb medical device in the EU.
Differentiator
Problem solved
Functional benefit
Products and services
- Symptomate Web Application Browser-based self-service symptom checker that lets users add symptoms and risk factors, answer adaptive interview questions, and receive AI-powered assessments of most probable conditions with explanations and recommended levels of care. Targets individual consumers (free) and serves as the entry point to the Infermedica B2B licensing offering.
- Symptomate Mobile App iOS and Android mobile application delivering the Symptomate symptom checking and triage experience on smartphones and tablets. Available free on Google Play (4.5 stars) and the App Store (4.7 stars) for individual consumers worldwide.
- Infermedica Follow-Up Standalone follow-up interview service that re-engages users after an initial Symptomate assessment to track changes in health status and produce Follow-Up Results. Available only to users in the United States as an add-on to the core symptom checker.
- Health Report Standalone intake survey service that collects detailed information about risk factors, symptoms, and health history and organizes it for the user's reference. Available exclusively to users in the United States as an add-on to the core symptom checker.
Quantifiable outcome
- 27+ million interviews performed since 2012
- +2 more outcomes
Companies that use Symptomate
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles2 records
Symptomate technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability4 records
Feature6 records
Symptomate partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- InfermedicacoreSymptomate is powered by Infermedica technology. Infermedica Sp. z o.o. is the parent company and service provider for Symptomate, headquartered in Wrocław, Poland. The symptom checker technology is licensed to healthcare facilities, insurance providers, and other companies through Infermedica's platform.
Scale indicators5 records
Recent moves6 records
Expansion highlights5 records
Symptomate competitors and assessment
Company assessmentDirect peers
- Ada Health: Ada Health operates a globally deployed AI symptom assessment and triage app widely cited as a direct competitor to Symptomate. Both target individual consumers with a free symptom checker while also licensing to health systems, insurers, and pharmaceutical companies, with overlapping EU regulatory positioning (CE-marked medical device) and similar B2B go-to-market.
- Babylon Health (eMed / Alkemi): Babylon Health (now operating under eMed in the US) builds AI-driven symptom checking, triage, and virtual care consultation services for insurers and providers. It competes head-to-head with Symptomate for enterprise health-plan and employer contracts and is the most frequently cited direct competitor in AI symptom triage.
- K Health: K Health offers an AI-guided symptom intake that connects to live physician consultations, primarily targeting US health plans and consumers. It overlaps directly with Symptomate's triage use case and competes for payer and employer contracts, particularly in the US market where Symptomate's general wellness positioning is a relative limitation.
- Buoy Health: Buoy Health provides an AI symptom checker and triage platform that is white-labeled into health plans, hospital systems, and employer benefits programs in the US. Its product, customer segments, and B2B licensing model closely mirror Symptomate's platform strategy.
- Mediktor: Mediktor is a Spanish-based AI symptom checker and triage assistant sold to hospitals, insurers, and digital health platforms. It is one of Symptomate's closest European competitors, particularly in the payer-sponsored telehealth and clinical decision support subcategories.
Broad incumbents
- Mayo Clinic Symptom Checker: The Mayo Clinic Symptom Checker offers consumer-facing triage content from a recognized clinical brand, providing an alternative destination that competes with Symptomate for top-of-funnel symptom searches. While not a B2B triage platform, it overlaps meaningfully in consumer SEO and brand-trust positioning.
- WebMD: WebMD is a large incumbent consumer health information destination with a built-in symptom checker, monetized primarily through advertising and sponsored content. It competes with Symptomate for organic traffic and consumer mindshare in the self-triage category.
- Healthline / Healthline Symptom Checker: Healthline is a major consumer health content publisher (owned by RVO Health) with a symptom checker tool that competes with Symptomate in the consumer self-triage category. Brand authority and SEO scale make it a meaningful incumbent alternative for individual users.
Emerging players
- Isabel Healthcare: Isabel Healthcare provides a differential diagnosis and clinical decision support tool used by clinicians at the point of care. It overlaps with Symptomate's diagnostic decision support layer and represents a peer in the clinical CDS sub-segment, though it focuses on professional users rather than consumers.
- GYANT: GYANT is a conversational AI triage and care navigation tool deployed by health systems and insurers. Its product functionality and B2B sales motion closely overlap with Symptomate's enterprise licensing offering, particularly in the US payer channel.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
Symptomate social profiles
Digital presenceSymptomate compliance and trust
Trust signalCompliance4 records
Symptomate financial estimates
Financial estimateRevenue estimate
Valuation estimate
Symptomate leadership team
Management profileNumber of profiles
Symptomate funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Symptomate M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Symptomate
What does Symptomate do?
Symptomate is an AI-powered symptom checker and digital triage platform that allows users to input symptoms, risk factors, and health information through an adaptive interview to receive probability-based assessments of potential conditions along with five levels of care recommendations. The platform is delivered as a free consumer-facing web and mobile application (iOS/Android) and is also licensed to healthcare facilities, insurance providers, and other enterprises for integration into their preliminary symptom assessment and triage workflows.
Is Symptomate a public or private company?
Symptomate is a private company. It is classified as corporate owned and is currently operating.
When was Symptomate founded?
Symptomate was founded in 2012. It employs 11 to 50 people.
Where is Symptomate based?
Symptomate is headquartered in Wroclaw, Poland, in the Europe region.
How does Symptomate make money?
Two revenue lines are on record. Consumer Self-Service (Free) is the primary driver. The others are B2B Enterprise Licensing.
Who are Symptomate's main competitors?
Direct peers on record are Ada Health, Babylon Health (eMed / Alkemi), K Health, Buoy Health and Mediktor. Broad incumbents are Mayo Clinic Symptom Checker, WebMD and Healthline / Healthline Symptom Checker. Emerging players are Isabel Healthcare and GYANT.
Does Symptomate have an API?
No public API is recorded for Symptomate.
What industry is Symptomate in?
Symptomate's product category is Digital Health Triage Software. Its primary akta.pro industry code is HLALAJAB, Symptom Checker & Self-Triage Platforms, with a secondary code of HLACAGAA, Diagnostic & Triage Decision Support. Its NAICS code is 62151 and its SIC code is 7372.